Related Experiment Video
Updated: Jan 20, 2026

Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
Published on: September 27, 2024
Medication-Related Osteonecrosis of the Jaws
Cesar A Migliorati1, Michael T Brennan2, Douglas E Peterson3
1Department of Oral and Maxillofacial Diagnostic Sciences, University of Florida College of Dentistry, Gainesville, FL.
Abstract:
Medication-related osteonecrosis of the jaw is an oral complication in cancer patients being treated with either antiresorptive or antiangiogenic drugs. The first reports of MRONJ were published in 2003. Hundreds of manuscripts have been published in the medical and dental literature describing the complication, clinical and radiographic signs and symptoms, possible pathophysiology, and management. Despite this extensive literature, the pathobiological mechanisms by which medication-related osteonecrosis of the jaw develops have not yet been fully delineated. The aim of this manuscript is to present current knowledge about the complication ragarding to the definition, known risk factors, and clinical management recommendations. Based on this current state of the science, we also propose research directions that have potential to enhance the management of future oncology patients who are receiving these agents.
Related Concept Videos
Inhaled Medications
Heart Failure V: Medical Management
Endocarditis III: Medical Management
Myocarditis III: Medical Management
Pericarditis III: Medical Management
Nephrotic Syndrome II : Assessment and Medical Management

